Editorial

Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials

Chung-Tsen Hsueh1, Delong Liu2* and Hong Wang3*

Author Affiliations

1 Division of Hematology and Oncology, Loma Linda University, Loma Linda, CA, USA

2 New York Medical College and Westchester Medical Center, Valhalla, NY 10595, USA

3 Department of Pharmacology, Temple University School of Medicine, 3420 North Broad Street, Philadelphia, PA 19140, U.S.A

For all author emails, please log on.

Biomarker Research 2013, 1:1 doi:10.1186/2050-7771-1-1

Published: 16 January 2013

First paragraph (this article has no abstract)

A biomarker, as defined by Wikipedia, “is an indicator of a biological state. It is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.”